$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Aurinia Pharmaceuticals, Inc.
Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics
Sector
Health Technology
CEO
Richard M. Glickman
Industry
Biotechnology
Exchange
NAS
Website
Top Stories
Coming soon.